Charles River Laboratories International (CRL) Change in Receivables (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Change in Receivables of -$27.6 million in Q4 2025, down 3.89% quarter-over-quarter from -$26.6 million in Q3 2025, and down 734.27% on a YoY basis from $4.4 million in Q4 2024.
Charles River Laboratories International (CRL) Change in Receivables (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Change in Receivables history runs 17 years deep, the most recent figure standing at -$27.6 million for Q4 2025.
- In Q4 2025, Change in Receivables fell 734.27% year-over-year to -$27.6 million; the TTM figure through Dec 2025 stood at -$35.7 million (down 65.36% YoY), while the FY2025 annual figure was -$35.7 million, down 65.36% from the prior year.
- Change in Receivables was -$27.6 million for Q4 2025 at Charles River Laboratories International, down from -$26.6 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $59.7 million in Q2 2022 to a low of -$27.6 million in Q4 2025.
- Historically, Change in Receivables has averaged $7.7 million across 5 years, with a median of $3.8 million in 2021.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables jumped 1135.05% in 2022, then tumbled 734.27% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$9.0 million in 2021, then sank by 163.41% to -$23.6 million in 2022, then decreased by 8.68% to -$25.6 million in 2023, then soared by 87.09% to -$3.3 million in 2024, then sank by 734.27% to -$27.6 million in 2025.
- The last three Change in Receivables figures came in at -$27.6 million (Q4 2025), -$26.6 million (Q3 2025), and -$10.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | -12.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 121.07 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -65.11 Mn |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | -27.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -27.63 Mn |
| Dec 27, 2025 | -27.63 Mn |
| Sep 27, 2025 | -26.60 Mn |
| Sep 27, 2025 | -26.60 Mn |
| Jun 28, 2025 | -10.86 Mn |
| Jun 28, 2025 | -10.86 Mn |
| Mar 29, 2025 | 29.35 Mn |
| Mar 29, 2025 | 29.35 Mn |
| Dec 28, 2024 | -3.31 Mn |
| Dec 28, 2024 | -3.31 Mn |
| Sep 28, 2024 | -17.23 Mn |
| Sep 28, 2024 | -17.23 Mn |
| Jun 29, 2024 | -18.35 Mn |
| Jun 29, 2024 | -18.35 Mn |
| Mar 30, 2024 | 17.28 Mn |
| Mar 30, 2024 | 17.28 Mn |
| Dec 30, 2023 | -25.65 Mn |
| Dec 30, 2023 | -25.65 Mn |
| Sep 30, 2023 | 10.83 Mn |
| Sep 30, 2023 | 10.83 Mn |